Annual Revenue
N/A
31 December 2023
Summary:
GT Biopharma annual revenue is not available.GTBP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
GT Biopharma quarterly revenue is not available.GTBP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
GT Biopharma TTM revenue is not available.GTBP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
GTBP Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
GT Biopharma Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | $27.00 K(-55.7%) | - | - |
June 2015 | - | $20.00 K(+185.7%) | $63.00 K(-7.4%) |
Mar 2015 | - | $7000.00(-78.8%) | $68.00 K(+11.5%) |
Dec 2014 | $61.00 K(-83.4%) | $33.00 K(+1000.0%) | $61.00 K(-11.6%) |
Sept 2014 | - | $3000.00(-88.0%) | $69.00 K(-72.3%) |
June 2014 | - | $25.00 K(-39.0%) | $249.00 K(-32.3%) |
Dec 2013 | $368.00 K(+7.6%) | $41.00 K(-77.6%) | $368.00 K(-32.6%) |
Sept 2013 | - | $183.00 K(+226.8%) | $546.00 K(+13.0%) |
June 2013 | - | $56.00 K(-36.4%) | $483.00 K(+12.9%) |
Mar 2013 | - | $88.00 K(-59.8%) | $428.00 K(+25.5%) |
Dec 2012 | $342.00 K(+1215.4%) | $219.00 K(+82.5%) | $341.00 K(+172.8%) |
Sept 2012 | - | $120.00 K(>+9900.0%) | $125.00 K(+1685.7%) |
June 2012 | - | $1000.00(0.0%) | $7000.00(0.0%) |
Mar 2012 | - | $1000.00(-66.7%) | $7000.00(-73.1%) |
Dec 2011 | $26.00 K(+136.4%) | $3000.00(+50.0%) | $26.00 K(-23.5%) |
Sept 2011 | - | $2000.00(+100.0%) | $34.00 K(+6.3%) |
June 2011 | - | $1000.00(-95.0%) | $32.00 K(+3.2%) |
Mar 2011 | - | $20.00 K(+81.8%) | $31.00 K(+181.8%) |
Dec 2010 | $11.00 K(-77.1%) | $11.00 K(-15.4%) | $11.00 K(-77.1%) |
Dec 2009 | $48.00 K(-95.8%) | $13.00 K(-62.9%) | $48.00 K(-90.4%) |
June 2009 | - | $35.00 K(-76.8%) | $501.00 K(-56.1%) |
Dec 2008 | $1.14 M(-81.1%) | $151.00 K(-52.1%) | $1.14 M(-50.7%) |
Sept 2008 | - | $315.00 K(-19.2%) | $2.31 M(-34.3%) |
June 2008 | - | $390.00 K(+36.4%) | $3.52 M(-28.8%) |
Mar 2008 | - | $286.00 K(-78.4%) | $4.94 M(-18.3%) |
Dec 2007 | $6.05 M(+4.7%) | $1.32 M(-13.0%) | $6.05 M(-1.2%) |
Sept 2007 | - | $1.52 M(-16.1%) | $6.12 M(+0.1%) |
June 2007 | - | $1.81 M(+30.3%) | $6.11 M(+8.1%) |
Mar 2007 | - | $1.39 M(-0.3%) | $5.65 M(-2.1%) |
Dec 2006 | $5.78 M(+131.3%) | $1.40 M(-7.7%) | $5.78 M(+11.9%) |
Sept 2006 | - | $1.51 M(+11.5%) | $5.16 M(+23.4%) |
June 2006 | - | $1.36 M(-10.4%) | $4.18 M(+23.7%) |
Mar 2006 | - | $1.51 M(+94.2%) | $3.38 M(+35.3%) |
Dec 2005 | $2.50 M(+5.6%) | $779.00 K(+46.4%) | $2.50 M(+17.3%) |
Sept 2005 | - | $532.00 K(-4.1%) | $2.13 M(-16.5%) |
June 2005 | - | $555.00 K(-12.0%) | $2.55 M(+5.0%) |
Mar 2005 | - | $631.00 K(+53.9%) | $2.43 M(+2.7%) |
Dec 2004 | $2.36 M(-13.7%) | $410.00 K(-57.0%) | $2.36 M(-19.2%) |
Sept 2004 | - | $954.00 K(+120.3%) | $2.92 M(+15.6%) |
June 2004 | - | $433.00 K(-23.6%) | $2.53 M(-8.3%) |
Mar 2004 | - | $567.00 K(-41.5%) | $2.76 M(+0.7%) |
Dec 2003 | $2.74 M(+33.7%) | $970.00 K(+73.2%) | $2.74 M(+22.0%) |
Sept 2003 | - | $560.00 K(-15.3%) | $2.25 M(+6.3%) |
June 2003 | - | $661.00 K(+20.4%) | $2.11 M(-2.8%) |
Mar 2003 | - | $549.00 K(+15.6%) | $2.17 M(+5.9%) |
Dec 2002 | $2.05 M(-30.9%) | $475.00 K(+11.5%) | $2.05 M(-1.8%) |
Sept 2002 | - | $426.00 K(-40.9%) | $2.09 M(-9.3%) |
June 2002 | - | $721.00 K(+68.5%) | $2.30 M(-5.0%) |
Mar 2002 | - | $428.00 K(-16.6%) | $2.42 M(-18.4%) |
Dec 2001 | $2.97 M(-16.2%) | $513.00 K(-19.8%) | $2.97 M(-8.2%) |
Sept 2001 | - | $640.00 K(-23.9%) | $3.23 M(-11.0%) |
June 2001 | - | $841.00 K(-13.6%) | $3.63 M(+1.7%) |
Mar 2001 | - | $973.00 K(+24.9%) | $3.57 M(+0.8%) |
Dec 2000 | $3.54 M(-50.6%) | $779.00 K(-25.0%) | $3.54 M(-26.6%) |
Sept 2000 | - | $1.04 M(+33.4%) | $4.83 M(+3.0%) |
June 2000 | - | $779.00 K(-17.4%) | $4.69 M(-29.1%) |
Mar 2000 | - | $943.00 K(-54.3%) | $6.61 M(-7.8%) |
Dec 1999 | $7.17 M(+40.5%) | $2.06 M(+129.4%) | $7.17 M(+12.0%) |
Sept 1999 | - | $900.00 K(-66.7%) | $6.40 M(-1.5%) |
June 1999 | - | $2.70 M(+80.0%) | $6.50 M(+22.6%) |
Mar 1999 | - | $1.50 M(+15.4%) | $5.30 M(+3.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 1998 | $5.10 M(0.0%) | $1.30 M(+30.0%) | $5.10 M(-8.9%) |
Sept 1998 | - | $1.00 M(-33.3%) | $5.60 M(-6.7%) |
June 1998 | - | $1.50 M(+15.4%) | $6.00 M(+15.4%) |
Mar 1998 | - | $1.30 M(-27.8%) | $5.20 M(+2.0%) |
Dec 1997 | $5.10 M(+6.3%) | $1.80 M(+28.6%) | $5.10 M(+24.4%) |
Sept 1997 | - | $1.40 M(+100.0%) | $4.10 M(0.0%) |
June 1997 | - | $700.00 K(-41.7%) | $4.10 M(-10.9%) |
Mar 1997 | - | $1.20 M(+50.0%) | $4.60 M(-4.2%) |
Dec 1996 | $4.80 M(-5.9%) | $800.00 K(-42.9%) | $4.80 M(-2.0%) |
Sept 1996 | - | $1.40 M(+16.7%) | $4.90 M(+6.5%) |
June 1996 | - | $1.20 M(-14.3%) | $4.60 M(+2.2%) |
Mar 1996 | - | $1.40 M(+55.6%) | $4.50 M(-13.5%) |
Dec 1995 | $5.10 M(+45.7%) | $900.00 K(-18.2%) | $5.20 M(-14.8%) |
Sept 1995 | - | $1.10 M(0.0%) | $6.10 M(+13.0%) |
June 1995 | - | $1.10 M(-47.6%) | $5.40 M(+17.4%) |
Mar 1995 | - | $2.10 M(+16.7%) | $4.60 M(+31.4%) |
Dec 1994 | $3.50 M(+16.7%) | $1.80 M(+350.0%) | $3.50 M(+59.1%) |
Sept 1994 | - | $400.00 K(+33.3%) | $2.20 M(-24.1%) |
June 1994 | - | $300.00 K(-70.0%) | $2.90 M(-17.1%) |
Mar 1994 | - | $1.00 M(+100.0%) | $3.50 M(+20.7%) |
Dec 1993 | $3.00 M(+7.1%) | $500.00 K(-54.5%) | $2.90 M(-3.3%) |
Sept 1993 | - | $1.10 M(+22.2%) | $3.00 M(+3.4%) |
June 1993 | - | $900.00 K(+125.0%) | $2.90 M(+3.6%) |
Mar 1993 | - | $400.00 K(-33.3%) | $2.80 M(+3.7%) |
Dec 1992 | $2.80 M(+3.7%) | $600.00 K(-40.0%) | $2.70 M(+3.8%) |
Sept 1992 | - | $1.00 M(+25.0%) | $2.60 M(0.0%) |
June 1992 | - | $800.00 K(+166.7%) | $2.60 M(+8.3%) |
Mar 1992 | - | $300.00 K(-40.0%) | $2.40 M(-14.3%) |
Dec 1991 | $2.70 M(-43.8%) | $500.00 K(-50.0%) | $2.80 M(-26.3%) |
Sept 1991 | - | $1.00 M(+66.7%) | $3.80 M(0.0%) |
June 1991 | - | $600.00 K(-14.3%) | $3.80 M(-13.6%) |
Mar 1991 | - | $700.00 K(-53.3%) | $4.40 M(-8.3%) |
Dec 1990 | $4.80 M(-5.9%) | $1.50 M(+50.0%) | $4.80 M(+2.1%) |
Sept 1990 | - | $1.00 M(-16.7%) | $4.70 M(+2.2%) |
June 1990 | - | $1.20 M(+9.1%) | $4.60 M(-9.8%) |
Mar 1990 | - | $1.10 M(-21.4%) | $5.10 M(0.0%) |
Dec 1989 | $5.10 M(+59.4%) | $1.40 M(+55.6%) | $5.10 M(+10.9%) |
Sept 1989 | - | $900.00 K(-47.1%) | $4.60 M(+4.5%) |
June 1989 | - | $1.70 M(+54.5%) | $4.40 M(+15.8%) |
Mar 1989 | - | $1.10 M(+22.2%) | $3.80 M(+18.8%) |
Dec 1988 | $3.20 M(+39.1%) | $900.00 K(+28.6%) | $3.20 M(+18.5%) |
Sept 1988 | - | $700.00 K(-36.4%) | $2.70 M(0.0%) |
June 1988 | - | $1.10 M(+120.0%) | $2.70 M(+22.7%) |
Mar 1988 | - | $500.00 K(+25.0%) | $2.20 M(-4.3%) |
Dec 1987 | $2.30 M(-23.3%) | $400.00 K(-42.9%) | $2.30 M(+9.5%) |
Sept 1987 | - | $700.00 K(+16.7%) | $2.10 M(-8.7%) |
June 1987 | - | $600.00 K(0.0%) | $2.30 M(-17.9%) |
Mar 1987 | - | $600.00 K(+200.0%) | $2.80 M(0.0%) |
Dec 1986 | $3.00 M(+25.0%) | $200.00 K(-77.8%) | $2.80 M(-12.5%) |
Sept 1986 | - | $900.00 K(-18.2%) | $3.20 M(+18.5%) |
June 1986 | - | $1.10 M(+83.3%) | $2.70 M(+17.4%) |
Mar 1986 | - | $600.00 K(0.0%) | $2.30 M(-4.2%) |
Dec 1985 | $2.40 M(-50.0%) | $600.00 K(+50.0%) | $2.40 M(-20.0%) |
Sept 1985 | - | $400.00 K(-42.9%) | $3.00 M(-21.1%) |
June 1985 | - | $700.00 K(0.0%) | $3.80 M(-11.6%) |
Mar 1985 | - | $700.00 K(-41.7%) | $4.30 M(-10.4%) |
Dec 1984 | $4.80 M(+9.1%) | - | - |
Dec 1984 | - | $1.20 M(0.0%) | $4.80 M(+33.3%) |
Sept 1984 | - | $1.20 M(0.0%) | $3.60 M(+50.0%) |
June 1984 | - | $1.20 M(0.0%) | $2.40 M(+100.0%) |
Mar 1984 | - | $1.20 M | $1.20 M |
Feb 1984 | $4.40 M | - | - |
FAQ
- What is the all time high annual revenue for GT Biopharma?
- What is the all time high quarterly revenue for GT Biopharma?
- What is the all time high TTM revenue for GT Biopharma?
What is the all time high annual revenue for GT Biopharma?
GT Biopharma all-time high annual revenue is $7.17 M
What is the all time high quarterly revenue for GT Biopharma?
GT Biopharma all-time high quarterly revenue is $2.70 M
What is the all time high TTM revenue for GT Biopharma?
GT Biopharma all-time high TTM revenue is $7.17 M